Dermapharm tops German small-caps on Q1 beat

Dermapharm Holding SE

15/05/2023 08:42

** Shares in Dermapharm  DMPG.DE  rise 4.2% to top the
German small-cap index  .SDAXI  after the drugmaker beat Q1
expectations supported by its acquisition of Arkopharma Group
    ** The Bavarian company reports Q1 consolidated revenue of
319.1 million euros ($351.3 million), up 37.8% from last year
    ** "Dermapharm released a strong set of 1Q figures with a
12% beat on topline and 16% on adj. EBITDA vs. consensus,"
Jefferies says, adding that all segments contributed to the
growth
    ** Dermapharm, which is up 22% YTD, is on track for best day
since early January

($1 = 0.9084 euros)

 (Reporting by Tristan Veyet)
 ((Tristan.chabba@thomsonreuters.com))